EPCAM and colorectal cancer: In this study, a third-generation EpCAM-CAR was designed against colorectal cancer-specific antigen EpCAM and successfully constructed by lentiviral infection into T cells, and the effectiveness of this EpCAM-CAR-T cell was verified both in vitro and in vivo.